Skip to main content

Rapacuronium Side Effects

Applies to rapacuronium: intravenous powder for injection.

Cardiovascular

Cardiovascular effects including hypotension (5.2%), tachycardia (3.2%), and bradycardia (1.5%) have been reported.[Ref]

Respiratory

Respiratory effect including bronchospasm (3.2%) have been reported.[Ref]

References

1. "Product Information. Raplon (rapacuronium)." Organon (2001):

2. Goudsouzian NG "Rapacuronium and bronchospasm." Anesthesiology 94 (2001): 727-8

3. Kron SS "Severe bronchospasm and desaturation in a child associated with rapacuronium." Anesthesiology 94 (2001): 923-4

4. Naguib M "How serious is the bronchospasm induced by rapacuronium?." Anesthesiology 94 (2001): 924-5

5. Meakin GH, Pronske EH, Lerman J, Orr R, Joffe D, Savaree AM, Lynn AM "Bronchospasm after rapacuronium in infants and children." Anesthesiology 94 (2001): 926-7

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.